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⁎ Corresponding author. E-mail address: kelton.tremellen@flinders.edu.au (K. Tremellen).Abstract Compared with natural conception, IVF is an effective form of fertility treatment associated with higher rates of obstetric
complications and poorer neonatal outcomes. While some increased risk is intrinsic to the infertile population requiring treatment, the
practice of multiple embryo transfer contributes to these complications and outcomes, especially concerning its role in higher order
pregnancies. As a result, several jurisdictions (e.g. Sweden, Belgium, Turkey, and Quebec) have legally mandated elective single-embryo
transfer (eSET) for youngwomen.We accept that in very high-risk scenarios (e.g. past history of preterm delivery and poormaternal health),
double-embryo transfer (DET) should be prohibited due to unacceptably high risks. However, we argue that mandating eSET for all young
women can be considered an unacceptable breach of patient autonomy, especially since DET offers certain women financial and social
advantages. We also show that mandated eSET is inconsistent with other practices (e.g. ovulation induction and intrauterine insemination–
ovulation induction) that can expose women and their offspring to risks associated with multiple pregnancies. While defending the option of
DET for certain women, some recommendations are offered regarding IVF practice (e.g. preimplantation genetic screening and better
support of IVF and maternity leave) to incentivise patients to choose eSET.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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It is well recognised that multiple births, usually the result
of the transfer of more than one embryo, pose substantial
risks to both mother and infants, and therefore elective
single embryo transfer (eSET) should be promoted whenever
appropriate. The human female body, with its single uterine
cavity and predominance of mono-ovular cycles, has evolved
to carry optimally only one baby at a time. Therefore, it
can be argued that double-embryo transfer (DET) and its
associated risk of twin pregnancy goes against what nature
intended, courting obstetric complications. Overall, pre-tions are threefold higher
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/by-nc-nd/4.0/).than in the general population, with low birth weight
also being more common (Sunderam et al., 2014). These
differences are even more marked in IVF twin pregnancies,
with rates of preterm delivery being five times higher than
singleton IVF pregnancies, and six times more likely to result
in a low birth weight child (Sunderam et al., 2014).
Due to the increased risks associated with IVF twin
pregnancies, a number of European countries have now
moved to mandated eSET in good prognosis patients
(Bissonnette et al., 2011; Maheshwari et al., 2011). For
example, Turkey introduced legislation in 2010 which
mandates, regardless of embryo quality, that clinicians
may transfer a maximum of one embryo in the first one or
two cycles in women under the age of 35 (and two embryosn access article under the CC BY-NC-ND license
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women 35 years or older (Ercan et al., 2014). Sweden and
Belgium have similar restrictions mandating eSET in young
individuals, with rates of eSET also exceeding 50% in many
European countries (Maheshwari et al., 2011; Kupka et al.,
2014). In the UK, the National Institute for Clinical
Effectiveness (NICE) issued guidance in 2013 that instructs
clinicians to use SET for first cycles in women under 37 years
of age and for second cycles if a top quality embryo is
available (NICE, 2013), while in Australia and New Zealand,
the vast majority (85.2%) of embryo transfer cycles for
women under 35 years of age are currently conducted as SET
(Macaldowie et al., 2014). In the USA, the American Society
for Reproductive Medicine (ASRM) guidelines (ASRM, 2013)
state that for women under 35 years of age with a
favourable prognosis (first cycle of IVF or prior IVF success,
good morphology embryos), SET should be offered, while
recommending that no more than two embryos should be
transferred at a time. However, in the USA the rate of eSET
in women under 35 years of age is only 12.2% (Sunderam et
al., 2014), despite guidelines suggesting that these patients
should be offered eSET (ASRM, 2013). As a result, 46% of
infants born from assisted reproduction techniques in the
USA were multiple birth deliveries (43% twins, 3% triplets),
compared with only 3.4% in the general population
(Sunderam et al., 2014).
With such vastly different IVF practices existing around
the world, it is timely to ask the question, ‘What is the
correct approach?’ There are two main arguments proposed
in favour of a mandated eSET approach. Firstly, DET and a
potential multiple pregnancy increases the obstetric risks
for women, as well as risks for the children conceived
(McLernon et al., 2010; Pinborg et al., 2003; Sazonova et al.,
2013). Therefore many commentators argue from a risk
minimisation perspective that DET should be avoided at all
costs, with the European Society of Human Reproduction and
Embryology (ESHRE) Task Force on Ethics and Law even going
as far as stating that multiple pregnancies should be
reported as IVF complications, not successes (ESHRE Task
Force on Ethics and Law, 2003). Secondly, as health care
costs related to management of obstetric complications and
prematurity are increased in multiple pregnancies, one can
also argue from a health economics perspective that eSET
should be mandated (Chambers et al., 2014). However, this
paper will critically analyse each of these arguments,
drawing on four widely endorsed bioethical principles
(beneficence, non-maleficence, justice, and respect for
patient autonomy) (Beauchamp and Childress, 2001), all
commonly used in clinical decision making (Ebbesen and
Pedersen, 2007). We argue that in the countries such as the
USA, where the majority of IVF costs are borne by the
patient, mandated SET is not ethically justifiable.
Beneficence and non-maleficence—Reward is
always proportional to risk!
The principle of beneficence requires that doctors' actions
benefit patients. However, whenever doctors attempt to
produce a medical benefit for patients through treatment,
they also place them at risk of harm, since every medical
intervention has the potential for adverse outcome. Duringmedical training, physicians are taught the importance of
first avoiding doing harm to patients, or at least minimising
any such harm (non-maleficence). The key to being an
effective physician, the ‘art’ of medical practice, is for the
doctor to make a balanced judgement of the risks versus
benefits of a particular therapy. They are then able to
provide a treatment recommendation in light of individual
patients' needs and risk profile.
IVF treatment is relatively unique in medical care in that
it potentially leads to benefits and risks to both the
prospective mother and a third party—the resulting child.
Therefore, there is a potential tension between the wishes
or interests of one party (the parents) and that of another
(the child). It can be argued that a physician has a duty of
care to both their current patients (parents) and the future
child as several jurisdictions mandate that the doctor must
consider the welfare of the child when making decisions
regarding fertility treatment (HFEA, 2015; NHMRC, 2007).
The argument in favour of eSET is based on non-
maleficence, since it is clear that IVF pregnancies carry
higher risk than naturally conceived pregnancies, with this
risk being further compounded in multiple pregnancies
compared with singletons (ESHRE, 2000; Kjellberg et al.,
2006; Sullivan et al., 2012; Sutcliffe and Ludwig, 2007).
Furthermore, some may feel that eSET is equally beneficent,
since studies from Europe have reported that cumulative
pregnancy rates from consecutive eSET are not inferior to
those obtained from DET, yet result in a significantly
reduced risk of twins (Grady et al., 2012; Lukassen et al.,
2005; McLernon et al., 2010; Pandian et al., 2013; Thurin
et al., 2004). Does this justify a mandated policy of eSET in
all young women?
Firstly, being born prematurely is not necessarily in itself
a poor medical outcome. The majority of children born
prematurely (between 32 and 37 weeks) ultimately do very
well, leading productive adult lives with no major health
impediments (Teune et al., 2011). Although such children
have an increased risk of short-term and long-term prob-
lems, the absolute magnitude of this risk is low (for example,
0.43% of late preterm infants develop cerebral palsy, 0.81%
suffer mental retardation, an increase of approximately
0.3% compared with term infants) (Teune et al., 2011). In
order to put these risks into perspective, it should be noted
that an average individual's life time risk of death as a result
of a car accident in the USA is 0.52% (Bandolier, 2015). In
everyday life, as well as health care, it is impossible to
remove all risk without compromising quality of life or
potential benefits.
It is primarily the children born before 32 weeks, and
especially those born before 28 weeks, that run significant
risk of handicap, chronic health impairment, or even death
(Saigal and Doyle, 2008; Serenius et al., 2013). While
statistically such very premature deliveries are more
common with IVF twins, numerically they are still relatively
rare events. The Centers for Disease Control and Prevention
(CDC) data on IVF outcomes in the USA report that only 6.7%
of IVF twins deliver very prematurely (b32 weeks gestation)
(Sunderam et al., 2014). In another study comparing
obstetric outcomes resulting from eSET versus DET, the risk
of very premature delivery in the DET group was also 6%
(McLernon et al., 2010). Overall, a large Danish study
reported no significant increase in the rate of cerebral
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2.5%)(Pinborg et al., 2004). However, it is acknowledged
that DET is also associated with an increased risk of stillbirth
and neonatal death compared with eSET. For example, an
Australian registry study reported that the risk of perinatal
mortality following DET was 53% higher than those following
SET (a difference of 5.9 deaths per 1000 births), with even
singleton births following transfers of fresh DET having 1.3
times increased perinatal mortality compared with those
following transfers of fresh SET (Sullivan et al., 2012).
Next, simply showing that there are potential risks from
DET is not sufficient to prohibit it. DET has an unusual
feature because of the nature of the treatment—two
potential children with possible competing health interests.
Where two embryos are transferred, it is possible that one of
them will be harmed. That embryo is at higher risk than if
they had been transferred alone. Later in life, a surviving
child might complain that it would have been better (for
them) if their parents had only transferred them as a single
embryo. However, someone is only harmed if they are left in
a worse state than they would otherwise have been. Since a
possible alternative for the second embryo is that they will
never exist at all in the setting of eSET, it seems that this
child, later in life, could well claim to have actually
benefited from the DET decision (Wilkinson et al., 2015).
The observation that over 600,000 embryos currently remain
in cryo-storage in the USA, many long term (Nightlight.,
2015), supports the view that many ‘second embryos’ will
never be transferred. Furthermore, while we accept that
the moral rights of a 5-day-old embryo are inferior to those
of a foetus or child, they are not zero, and therefore still
need consideration when assessing the relative merits of a
policy of mandated eSET.
Discussions surrounding mandated eSET are often focused
on the potential harms of DET, rather than a considered
appraisal of its potential benefits. As between 30% and 50%
of good-quality blastocysts are genetically abnormal with no
potential for normal live birth, even in those women under
35 years of age (Franasiak et al., 2014), it makes sense that
the transfer of two good-quality embryos is more likely to
result in the delivery of at least one genetically normal
child than the transfer of only one embryo. Transfer of a
solitary fresh embryo, followed by a later transfer of a
frozen-thawed embryo, could produce comparable cumula-
tive pregnancy rates to a fresh DET, yet lower risk of twins
and their associated complications (Grady et al., 2012;
Lukassen et al., 2005; McLernon et al., 2010; Pandian et al.,
2013; Thurin et al., 2004). However, there are potential
costs from such an approach. Firstly, a frozen embryo may
not survive the thawing process. Secondly, many couples do
not return for a later frozen embryo transfer; either due to
psychological distress created by the initial failed fresh
transfer, financial impediments or a conscious decision to
limit the size of their family to one child after a successful
fresh eSET transfer (Brandes et al., 2009; Olivius et al.,
2004; Troude et al., 2014). As a result, the ‘real world’
outcome must mathematically equate with a significant
reduction in actual compared with potential cumulative
pregnancy rates. Thirdly, the approach of fresh eSET
followed by later frozen eSET takes considerably longer
(2–3 months) than the DET approach (1 month) for the same
cumulative pregnancy outcome—a significant disadvantagefor those women with diminished ovarian reserve and a
limited biological window of opportunity for pregnancy.
Finally, couples often seek to have two or more children to
complete their family. A DET with the delivery of twins may
be the best chance for a young woman with low ovarian
reserve to complete her family, since there is no guarantee
that a frozen embryo will result in a second child, and they
may no longer be able to produce any good-quality embryos
by the time they have weaned their first child and
recommenced IVF treatment.
From a parental perspective, there are also two distinct
advantages to DET and the subsequent delivery of twins.
Firstly, one pregnancy and period of child rearing is likely to
be less disruptive to a woman's career and earning potential
than two pregnancies and periods of maternity leave,
provided that the twin pregnancy does not result in
prolonged medical leave due to complications or mental
health issues from the increased stress of caring for twin
babies (Vilska et al., 2009). Furthermore, twins are
sometimes perceived to have a special emotional link,
forged by 9 months of close proximity in utero and shared
passage through life's developmental milestones (Segal,
1999). This special sibling emotional closeness may help
explain why as many as one in five couples actually desire
twins during IVF treatment (Ryan et al., 2007).
We are not arguing that DET is a superior approach,
overall, to sequential SET. Rather, it is not clear that
sequential SET is sufficiently more beneficial and less
harmful than DET that it should be mandated either by
legislation or through restrictive IVF funding arrangements.Justice
Justice in the context of medical care has two core
components—equity and distributive justice. Equity man-
dates that patients in similar situations should normally have
access to the same heath care opportunities. In European
countries such as Belgium, Denmark, France, and the
Netherlands, where the costs of IVF are heavily subsidised
by government or private insurance (Maheshwari et al.,
2011), it may be ethically justifiable to mandate eSET since
the patients are not materially financially disadvantaged if
their initial fresh eSET fails and they are required to proceed
with a follow-up frozen eSET. However, in countries such as
the USA, where the majority of IVF costs are borne by the
patients themselves, equity is simply not present as access
to fertility treatment is primarily dictated by a patient's
financial position, not their medical need. As such, it is
arguably unethical to mandate eSET for all couples,
irrespective of their financial position and subsequent
capacity to continue fertility care beyond their initial fresh
embryo transfer.
The second aspect to justice is distributive justice, which
emphasises that we have a moral obligation to distribute
scarce medical resources fairly among competing medical
needs (e.g. fertility care, oncology, infectious disease care,
etc.). A distributive justice argument might suggest that
eSET should be mandated for all young women because of
the increased costs of caring for mothers and babies as a
result of complications related to twin delivery (obstetric
complications, increased operative delivery, and neonatal
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long-term health costs associated with caring for a disabled
child). A recent UK economic modelling study found that
while DET did produce a higher cumulative live birth rate
compared with eSET, from a health service perspective, the
DET strategy cost an additional US$42,700 per extra live
birth in 32-year-old women and an extra US$29,000 per
extra live birth at 36 years of age (Scotland et al., 2011).
However, such modelling fails to account for the additional
long-term economic benefit to society derived from the
additional children born as a result of DET compared with
eSET. Economic modelling suggests that there is on average
US$155,000 net benefit to society for every child born
through IVF from lifelong tax contributions, even when
direct government costs such as education, health care, and
pensions are subtracted (Connolly et al., 2009). Further-
more, this UK economic analysis study made the assumption
that all women failing to conceive following eSET would
have a frozen embryo available and would return to have
that embryo transferred (Scotland et al., 2011). Unfortu-
nately, these assumptions do not reflect actual clinical
practice, where embryos of borderline quality can produce
healthy babies if transferred fresh (Oron et al., 2014) yet are
often not considered of sufficient quality to freeze.
Furthermore, financial pressures often cause women not to
return for a subsequent frozen embryo transfer. Failure to
consider all of these aspects significantly weakens the
financially based distributive justice argument against
DET. Indeed, these aspects may even favour DET in some
circumstances.Autonomy
Twin pregnancies certainly pose an increased risk to the
mother, as well as the child. Almost every obstetric
complication is more common in a twin compared with
singleton pregnancy, and even life after delivery is more
difficult for the parents of twins, with increased risk of
postnatal depression, and even divorce (Glazebrook et al.,
2004; Pinborg et al., 2003; Vilska et al., 2009). However,
autonomy dictates that as adults, we should have the
ultimate say on what treatment we receive, within a wide
band of reasonable risk, provided that we have been fully
informed of those risks and all the associated treatment
alternatives (Mill, 2015). The risk/benefit profile of DET
seems reasonable, and well within that which patients are
normally allowed to choose. Therefore, any increased risks
to the mother from DET are not sufficient justification to
mandate eSET.
Some commentators would suggest that any increased
risk to a child is ethically unacceptable since doctors and
parents both have a moral obligation to act in the best
interests of the child. However, there are multiple examples
where doctors and parents take actions which have the
potential to harm a child, yet are still considered to be
morally acceptable. For example, we allow parents to
decline immunisation of their children, despite the medical
evidence clearly showing that the benefits of immunisation
far outweigh the risks. Alternatively, we do not usually
incarcerate mothers who take drugs or drink excessive
amounts of alcohol during pregnancy, to prevent thepotential for harm to their unborn child. Instead, we try to
persuade these mothers to minimise risks to their child by
reducing or ceasing their potentially harmful behaviour,
through education and providing positive health opportuni-
ties (e.g. supportive housing where they can live safely and
have access to good quality nutrition). Similarly, education
of couples regarding the increased risks posed by twin
pregnancy is preferable to mandating eSET, since this
respects patient autonomy. And as we have argued, the
existence of a twin who may not be conceived if sequential
SET were employed further complicates doctors' duties to
the unborn child in this case.
A balanced approach—eSET is encouraged but
not mandated
Two points are clear and not under dispute regarding the
optimal number of embryos that may be transferred to a
young woman. Firstly, the transfer of three or more embryos
is no longer justifiable due to the risk of high-order
pregnancy and its associated risks. The current CDC data
suggest that in excess of 97% of triplet or higher order
assisted reproduction treatment pregnancies will be born
prematurely (Sunderam et al., 2014), an unacceptably high
risk in today's settings. Secondly, we also accept that the
safest approach to creating a healthy baby is through the
elective transfer of a single embryo. However, what is
currently under debate is whether it is ethically justifiable
to mandate eSET, depriving patients of the opportunity to
make an informed choice based on their own needs, while
also taking away the physician's ability to tailor treatment to
best meet their patient's medical and social circumstances.
We hope that after reading the preceding discussion, the
readership will agree that while eSET may be preferable,
mandated eSET is an unethical breach of patient autonomy
with modest, or even questionable, overall benefits.
Furthermore, if eSET is to be mandated because of concern
about the harms or costs of multiple pregnancy, then
consistency requires that we also ban ovulation induction
or mild ovarian stimulation intrauterine insemination (IUI);
both commonly practised fertility treatments with signifi-
cant risk of multiple pregnancies (Chaabane et al., 2015;
ESHRE, 2009; Kupka et al., 2014). Recent European data
suggest that 9.3% of IUI cycles will result in twin pregnan-
cies, and 0.5% in triplets (Kupka et al., 2014), whereas
North American data report that the risk of multiple
pregnancy in ovulation induction alone is increased fourfold
compared with natural conception and ninefold when
ovulation induction is combined with IUI (Chaabane et al.,
2015). The potential costs from abandoning ovulation
induction in anovular patients in favour of IVF with
mandated eSET would be considerable.
Going forward, we suggest that the optimal path for IVF
care is to continue to encourage eSET in young women,
supported by the provision of easily understood educational
aides (e.g. written patient information sheets and internet-
based educational videos) that provide a balanced view of
both the benefits and potential downsides of eSET com-
pared with DET. Interestingly, previous work has suggested
that an educational DVD is a more effective medium for
motivating patients to undertake eSET than a written
85Ethics of mandated single embryo transferbrochure containing the same information (Hope and
Rombauts, 2010).
Professional societies such as the ASRM and ESHRE should
continue to advocate better financial support of IVF care so
that couples' decisions on the number of embryos to be
transferred are less influenced by financial imperatives.
Experience from Belgium has shown that increased govern-
ment reimbursement of IVF, reducing the personal financial
burden on patients, does result in an increase uptake of
eSET, with the additional government financial costs being
almost completely covered by the associated savings from a
reduced need for neonatal care of twins (Ombelet et al.,
2005). Similarly, in the USA, a private health insurer has
agreed to cover the costs of a frozen cycle eSET if their
member undertakes an eSET in the initial fresh transfer, so
as to minimise the significant health costs associated with
twin pregnancies (Rosenthal, 2013). Finally, the provision of
paid maternity leave and the legislative protection of
women's jobs while on maternity leave may also help reduce
couples' preference for twin deliveries that complete their
family in one pregnancy, minimising perceived financial
hardship and career disruption.
Furthermore, we believe that guidelines need to be more
prescriptive regarding clinical circumstances in which it is
never justifiable to perform a multiple embryo transfer,
irrespective of a patient's wishes. Gleicher and Barad (2006)
have already suggested that in women with a history of
previous premature labour, uterine anomalies with a
significant risk of preterm labour, or a past history of
ruptured uterus, eSET should be mandated, as multiple
pregnancy is an unacceptable risk. These contraindications
to DET can of course be expanded to include any maternal
medical condition that is likely to compromise maternal
or foetal health due to the increased physiological bur-
den imposed by a twin pregnancy (e.g. major cardiac or
respiratory impairment or advanced maternal age). Further-
more, donor oocyte IVF could also be considered an absolute
contraindication to DET as it poses a significantly increased
risk of pre-eclampsia and associated complications to mother
and child (Le Ray et al., 2012), while also carrying a very high
risk of twin pregnancy if the oocytes of a young donor are used.
If professional societies such as ASRM or ESHRE were to publish
position statements that clearly outline clinical scenarios in
which DET is never acceptable, it is unlikely that doctors
would act contrary to this type of prescriptive guideline
because of fear of litigation and professional censure.
Finally, technological developments such as preimplan-
tation genetic screening (PGS) may ultimately reduce
the need for DET by providing optimal pregnancy rates
from the elective transfer of a single euploid embryo. A
recent meta-analysis of randomised controlled trials using PGS
in good prognosis young patients concluded that PGS does
result in superior implantation and clinical pregnancy rates
compared with the transfer of embryos selected solely on the
basis of morphology (Lee et al., 2015). Therefore, we believe
that technological approaches such as eSET following PGS are
superior to mandated eSET, since they respect patient
autonomy, while also optimising pregnancy outcomes. Those
countries that currently restrict transfer to eSET, either
through law or by prohibiting access to publically funded
DET, should revisit their policies and leave this important
decision up the patients and their treating physician.Declaration
KT has a financial interest in fertility care and holds stock in
Monash IVF, a publicly listed fertility provider. JS and DW
report no financial or commercial conflicts of interest.References
American Society for Reproductive Medicine, 2013. Practice
Committee of Society for Assisted Reproductive Technology.
Criteria for number of embryos to transfer: a committee opinion.
Fertil. Steril. 99 (1), 44–46 (Jan).
Bandolier, 2015. http://www.medicine.ox.ac.uk/bandolier/booth/
Risk/trasnsportpop.html (Accessed 18/6/15).
Beauchamp and Childress, 2001. Principles Biomedical Ethics, OUP.
fifth ed.
Bissonnette, F., Phillips, S.J., Gunby, J., Holzer, H., Mahutte, N.,
St-Michel, P., Kadoch, I.J., 2011 Oct. Working to eliminate
multiple pregnancies: a success story in Québec. Reprod.
BioMed. Online 23 (4), 500–504.
Brandes, M., van der Steen, J.O., Bokdam, S.B., Hamilton, C.J., de
Bruin, J.P., Nelen, W.L., Kremer, J.A., 2009 Dec. When and why
do subfertile couples discontinue their fertility care? A longitu-
dinal cohort study in a secondary care subfertility population.
Hum. Reprod. 24 (12), 3127–3135.
Chaabane, S., Sheehy, O., Monnier, P., Bissonnette, F., Trasler,
J.M., Fraser, W., Bérard, A., 2015. Association between ovarian
stimulators with or without intrauterine insemination, and
assisted reproductive technologies on multiple births. Am.
J. Obstet. Gynecol. http://dx.doi.org/10.1016/j.ajog.2015.06.
028 (Jun 12. pii: S0002–9378(15)00625–0).
Chambers, G.M., Hoang, V.P., Lee, E., Hansen, M., Sullivan, E.A.,
Bower, C., Chapman, M., 2014 Nov. Hospital costs of multiple-
birth and singleton-birth children during the first 5 years of life
and the role of assisted reproductive technology. JAMA Pediatr.
168 (11), 1045–1053.
Connolly, M., Gallo, F., Hoorens, S., Ledger, W., 2009 Mar. Assessing
long-run economic benefits attributed to an IVF-conceived
singleton based on projected lifetime net tax contributions in
the UK. Hum. Reprod. 24 (3), 626–632.
Ebbesen, M., Pedersen, B.D., 2007. Empirical investigation of the
ethical reasoning of physicians and molecular biologists–the
importance of the four principles of biomedical ethics. Philos.
Ethics Humanit. Med. 2, 23.
Ercan, C.M., Kerimoglu, O.S., Sakinci, M., Korkmaz, C., Duru, N.K.,
Ergun, A., 2014. Pregnancy outcomes in a university hospital after
legal requirement for single-embryo transfer. Eur. J. Obstet.
Gynecol. Reprod. Biol. 175, 163–166 (Apr).
ESHRE, 2003. Task Force on Ethics and Law. 6. Ethical issues related
to multiple pregnancies in medically assisted procreation. Hum.
Reprod. 18 (9), 1976–1979 (Sep).
ESHRE Capri Workshop Group, 2000 Aug. Multiple gestation pregnancy.
Hum. Reprod. 15 (8), 1856–1864.
ESHRE Capri Workshop Group, 2009. Intrauterine insemination.
Hum. Reprod. Update 15 (3), 265–277 (May-Jun).
Franasiak, J.M., Forman, E.J., Hong, K.H., Werner, M.D., Upham,
K.M., Treff, N.R., Scott Jr., R.T., 2014. The nature of aneuploidy
with increasing age of the female partner: a review of 15,169
consecutive trophectoderm biopsies evaluated with comprehen-
sive chromosomal screening. Fertil. Steril. 101 (3), 656–663
(Mar).
Glazebrook, C., Sheard, C., Cox, S., Oates, M., Ndukwe, G., 2004.
Parenting stress in first-time mothers of twins and triplets
conceived after in vitro fertilization. Fertil. Steril. 81 (3),
505–511 (Mar).
86 K Tremellen et al.Gleicher, N., Barad, D., 2006. The relative myth of elective single
embryo transfer. Hum. Reprod. 21 (6), 1337–1344 (Jun).
Grady, R., Alavi, N., Vale, R., Khandwala, M., McDonald, S.D., 2012.
Elective single embryo transfer and perinatal outcomes: a
systematic review and meta-analysis. Fertil. Steril. 97 (2),
324–331 (Feb).
Hope, N., Rombauts, L., 2010. Can an educational DVD improve the
acceptability of elective single embryo transfer? A randomized
controlled study. Fertil. Steril. 94 (2), 489–495 (Jul).
Human Fertilisation and Embryology Authority (HFEA), 2015. Welfare
of the child assessment. http://www.hfea.gov.uk/1414.html
(Accessed 21/1/16).
Kjellberg, A.T., Carlsson, P., Bergh, C., 2006. Randomized single
versus double embryo transfer: obstetric and paediatric outcome
and a cost-effectiveness analysis. Hum. Reprod. 21 (1), 210–216
(Jan).
Kupka, M.S., Ferraretti, A.P., de Mouzon, J., Erb, K., D'Hooghe, T.,
Castilla, J.A., Calhaz-Jorge, C., De Geyter, C., Goossens, V.,
2014. European IVF-Monitoring Consortium, for the European
Society of Human Reproduction and Embryology. Assisted
reproductive technology in Europe, 2010: results generated
from European registers by ESHRE†. Hum. Reprod. 29 (10),
2099–2113 (Oct 10).
Le Ray, C., Scherier, S., Anselem, O., Marszalek, A., Tsatsaris, V.,
Cabrol, D., Goffinet, F., 2012. Association between oocyte
donation and maternal and perinatal outcomes in women aged
43 years or older. Hum. Reprod. 27 (3), 896–901 (Mar).
Lee, E., Illingworth, P., Wilton, L., Chambers, G.M., 2015. The
clinical effectiveness of preimplantation genetic diagnosis for
aneuploidy in all 24 chromosomes (PGD-A): systematic review.
Hum. Reprod. 30 (2), 473–483 (Feb).
Lukassen, H.G., Braat, D.D., Wetzels, A.M., Zielhuis, G.A., Adang,
E.M., Scheenjes, E., Kremer, J.A., 2005. Two cycles with single
embryo transfer versus one cycle with double embryo transfer: a
randomized controlled trial. Hum. Reprod. 20 (3), 702–708
(Mar).
Macaldowie, A., Wang, Y., Chughtai, A., Chambers, G., 2014.
Assisted Reproductive Technology in Australia and New Zealand
2012. National Perinatal Epidemiology and Statistics Unit. The
University of New South Wales, Sydney.
Maheshwari, A., Griffiths, S., Bhattacharya, S., 2011. Global
variations in the uptake of single embryo transfer. Hum. Reprod.
Update 17 (1), 107–120 (Jan-Feb).
McLernon, D.J., Harrild, K., Bergh, C., Davies, M.J., de Neubourg,
D., Dumoulin, J.C., Gerris, J., Kremer, J.A., Martikainen, H.,
Mol, B.W., Norman, R.J., Thurin-Kjellberg, A., Tiitinen, A., van
Montfoort, A.P., van Peperstraten, A.M., Van Royen, E.,
Bhattacharya, S., 2010. Clinical effectiveness of elective single
versus double embryo transfer: meta-analysis of individual
patient data from randomised trials. BMJ 341c6945 (Dec 21).
Mill, J.S., 2015. On Liberty. Available online http://www.gutenberg.
org/ebooks/34901 (Accessed 19/7/15).
National Health and Medical Research Council (NHMRC), 2007. Ethical
guidelines on the use of assisted reproductive technology in clinical







Olivius, C., Friden, B., Borg, G., Bergh, C., 2004. Why do couples
discontinue in vitro fertilization treatment? A cohort study.
Fertil. Steril. 81 (2), 258–261 (Feb).
Ombelet, W., De Sutter, P., Van der Elst, J., Martens, G., 2005.
Multiple gestation and infertility treatment: registration, reflec-
tion and reaction–the Belgian project. Hum. Reprod. Update 11
(1), 3–14 (Jan-Feb).Oron, G., Son, W.Y., Buckett, W., Tulandi, T., Holzer, H., 2014. The
association between embryo quality and perinatal outcome of
singletons born after single embryo transfers: a pilot study. Hum.
Reprod. 29 (7), 1444–1451 (Jul).
Pandian, Z., Marjoribanks, J., Ozturk, O., Serour, G., Bhattacharya,
S., 2013. Number of embryos for transfer following in vitro
fertilisation or intra-cytoplasmic sperm injection. Cochrane
Database Syst. Rev. 7CD003416 (Jul 29).
Pinborg, A., Loft, A., Schmidt, L., Andersen, A.N., 2003. Morbidity
in a Danish national cohort of 472 IVF/ICSI twins, 1132 non-IVF/
ICSI twins and 634 IVF/ICSI singletons: health-related and social
implications for the children and their families. Hum. Reprod. 18
(6), 1234–1243 (Jun).
Pinborg, A., Loft, A., Schmidt, L., Greisen, G., Rasmussen, S.,
Andersen, A.N., 2004. Neurological sequelae in twins born after
assisted conception: controlled national cohort study. BMJ 329
(7461), 311 (Aug 7).
Rosenthal, M., 2013. Aetna follows best practices for IVF pro-
cedures. Incentives lower multiple births. http://managed
healthcareexecutive.modernmedicine.com/managed-healthcare-
executive/news/managed-healthcare-executive/news-analysis/
aetna-follows-best-prac (Last accessed 27/10/15).
Ryan, G.L., Sparks, A.E., Sipe, C.S., Syrop, C.H., Dokras, A., Van
Voorhis, B.J., 2007. A mandatory single blastocyst transfer policy
with educational campaign in a United States IVF program
reduces multiple gestation rates without sacrificing pregnancy
rates. Fertil. Steril. 88 (2), 354–360 (Aug).
Saigal, S., Doyle, L.W., 2008. An overview of mortality and sequelae
of preterm birth from infancy to adulthood. Lancet 371 (9608),
261–269 (Jan 19).
Sazonova, A., Källen, K., Thurin-Kjellberg, A., Wennerholm, U.B.,
Bergh, C., 2013. Neonatal and maternal outcomes comparing
women undergoing two in vitro fertilization (IVF) singleton
pregnancies and women undergoing one IVF twin pregnancy.
Fertil. Steril. 99 (3), 731–737 (Mar 1).
Scotland, G.S., McLernon, D., Kurinczuk, J.J., McNamee, P.,
Harrild, K., Lyall, H., Rajkhowa, M., Hamilton, M.,
Bhattacharya, S., 2011. Minimising twins in in vitro fertilisation:
a modelling study assessing the costs, consequences and cost-
utility of elective single versus double embryo transfer over a
20-year time horizon. BJOG 118 (9), 1073–1083 (Aug).
Segal, N.L., 1999. Entwined Lives: Twins and What They Tell Us
About Human Behavior. Dutton, New York.
Serenius, F., Källén, K., Blennow, M., Ewald, U., Fellman, V.,
Holmström, G., Lindberg, E., Lundqvist, P., Maršál, K., Norman,
M., Olhager, E., Stigson, L., Stjernqvist, K., Vollmer, B., 2013.
Strömberg B; EXPRESS Group. Neurodevelopmental outcome in
extremely preterm infants at 2.5 years after active perinatal
care in Sweden. J. Am. Med. Assoc. 309 (17), 1810–1820 (May 1).
Sullivan, E.A., Wang, Y.A., Hayward, I., Chambers, G.M.,
Illingworth, P., McBain, J., Norman, R.J., 2012. Single embryo
transfer reduces the risk of perinatal mortality, a population
study. Hum. Reprod. 27 (12), 3609–3615 (Dec).
Sunderam, S., Kissin, D.M., Crawford, S.B., Folger, S.G., Jamieson,
D.J., WD, Barfield, 2014. Centers for Disease Control and
Prevention (CDC). Assisted reproductive technology surveillance–
United States, 2011. MMWR Surveill. Summ. 63 (10), 1–28 (Nov 21).
Sutcliffe, A.G., Ludwig, M., 2007. Outcome of assisted reproduc-
tion. Lancet 370 (9584), 351–359 (Jul 28).
Teune, M.J., Bakhuizen, S., Gyamfi Bannerman, C., Opmeer, B.C.,
van Kaam, A.H., van Wassenaer, A.G., Morris, J.M., Mol, B.W.,
2011. A systematic review of severe morbidity in infants
born late preterm. Am. J. Obstet. Gynecol. 205 (4)
374.e1–9(Oct).
Thurin, A., Hausken, J., Hillensjö, T., Jablonowska, B., Pinborg, A.,
Strandell, A., Bergh, C., 2004. Elective single-embryo transfer
versus double-embryo transfer in in vitro fertilization. N. Engl.
J. Med. 351 (23), 2392–2402 (Dec 2).
87Ethics of mandated single embryo transferTroude, P., Guibert, J., Bouyer, J., La Rochebrochard E, de, DAIFI
Group, 2014. Medical factors associated with early IVF discon-
tinuation. Reprod. BioMed. Online 28 (3), 321–329 (Mar).
Vilska, S., Unkila-Kallio, L., Punamäki, R.L., Poikkeus, P., Repokari,
L., Sinkkonen, J., Tiitinen, A., Tulppala, M., 2009. Mental health
of mothers and fathers of twins conceived via assisted repro-
duction treatment: a 1-year prospective study. Hum. Reprod. 24
(2), 367–377 (Feb).Wilkinson, D., Schaefer, G.O., Tremellen, K., Savulescu, J., 2015.
Double trouble: should double embryo transfer be banned? Theor
Med Bioeth. 36 (2), 121–139 (Apr).
Received 12 August 2015; refereed 21 January 2016; accepted 2 February
2016.
